U.S. patent application number 13/656332 was filed with the patent office on 2013-05-02 for micropulse grid pattern laser treatment and methods.
This patent application is currently assigned to Iridex Corporation. The applicant listed for this patent is Iridex Corporation. Invention is credited to Dave Buzuwa, Kingman Yee.
Application Number | 20130110206 13/656332 |
Document ID | / |
Family ID | 48141376 |
Filed Date | 2013-05-02 |
United States Patent
Application |
20130110206 |
Kind Code |
A1 |
Yee; Kingman ; et
al. |
May 2, 2013 |
MICROPULSE GRID PATTERN LASER TREATMENT AND METHODS
Abstract
Embodiments of the invention provide systems and methods for
treating the retina and/or other areas of a patient's eye. The
procedures may involve using one or more treatment beams (e.g.,
lasers) to cause photocoagulation or laser coagulation to finely
cauterize ocular blood vessels and/or prevent blood vessel growth
to induce one or more therapeutic benefits. In other embodiments, a
series of short duration light pulses (e.g., between 5-15
microseconds) may be delivered to the retinal tissue with a thermal
relaxation time delay between the pulse to limit the temperature
rise of the target retinal tissue and thereby limit a thermal
effect to only the retinal pigment epithelial layer. Such
procedures may be used to treat diabetic retinopathy, macular
edema, and/or other conditions of the eye. The treatment beam may
be delivered within a treatment boundary or pattern defined on the
retina of the patient's eye.
Inventors: |
Yee; Kingman; (San Jose,
CA) ; Buzuwa; Dave; (Mountain View, CA) |
|
Applicant: |
Name |
City |
State |
Country |
Type |
Iridex Corporation; |
Mountain View |
CA |
US |
|
|
Assignee: |
Iridex Corporation
Mountain View
CA
|
Family ID: |
48141376 |
Appl. No.: |
13/656332 |
Filed: |
October 19, 2012 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
61549036 |
Oct 19, 2011 |
|
|
|
Current U.S.
Class: |
607/89 |
Current CPC
Class: |
A61B 2018/00589
20130101; A61F 9/00823 20130101; A61F 2009/00863 20130101; A61F
9/008 20130101; A61F 9/00821 20130101; A61B 2018/00315 20130101;
A61F 2009/00897 20130101 |
Class at
Publication: |
607/89 |
International
Class: |
A61F 9/008 20060101
A61F009/008 |
Claims
1. A method for treating an eye of a patient comprising: directing
an aiming beam onto retinal tissue of the patient's eye; defining,
via the aiming beam, a first target position and a second target
position; and delivering, via a treatment beam, a series of pulses
onto the retinal tissue at the first and second target positions to
treat the retinal tissue, wherein a duration of each pulse is
sufficiently short so as to avoid inducing traditional
photocoagulation of the retinal tissue, and wherein the series of
pulses directed to each position are sufficient to induce
photoactivation of a therapeutic healing at that position.
2. The method of claim 1, wherein the treatment beam scans between
the locations between the pulses of the series.
3. The method of claim 1, wherein the treatment beam delivers a
first series of pulses at the first target position before moving
to the second target position to deliver a second series of
pulses.
4. The method of claim 1, wherein the treatment beam comprises an
oval or oblong cross section configured to produce more circular
incident light profiles on the retinal tissue as the treatment beam
axis is scanned across the retinal tissue and the series of pulses
are delivered, the incident light profiles being more circular than
incident light profiles produced with circular cross section
treatment beams.
5. The method of claim 1, further comprising: scanning the
treatment beam from the first target position to the second target
position within a first area identified by the aiming beam; and
delivering the series of pulses between the first target position
and the second target position so that each pulse is delivered at a
different position between the first position and the second
position.
6. The method of claim 5, further comprising: rescanning the
treatment beam from the first target position to the second target
position within the first area; and delivering an additional series
of pulses between the first target position and the second target
position at approximately the same positions as the previous series
of pulses were delivered.
7. The method of claim 6, wherein the scan and pulse delivery
process comprises a first treatment cycle, the rescan and pulse
redelivery process comprises a second treatment cycle, and wherein
the method further comprises providing between about 10 and about
10,000 treatment cycles to treat the retinal tissue of the eye
within the first area.
8. The method of claim 5, wherein at least 9 pulses are delivered
between the first target position and the second target
position.
9. The method of claim 5, wherein the scan from the first target
position to the second target position is completed in a scan time
of between about 0.5 milliseconds and about 1.5 milliseconds.
10. The method of claim 9, wherein the scan from the first target
position to the second target position is completed in a scan time
of between about 0.9 milliseconds and about 1.1 milliseconds.
11. The method of claim 5, wherein the scan comprises a raster scan
pattern.
12. The method of claim 1, wherein the duration of each pulse is
sufficiently short so that an inner retinal temperature remains
below a threshold of coagulative damage.
13. The method of claim 1, wherein the duration of each pulse is
between about 5 microseconds and about 15 microseconds.
14. The method of claim 13, wherein the duration of each pulse is
between about 9 microseconds and about 11 microseconds.
15. A method for treating an eye of a patient comprising: directing
an aiming beam onto retinal tissue of the patient's eye; defining
via the aiming beam, a treatment boundary separating the retinal
tissue to a first area and a second area; scanning an axis of a
treatment beam within the first area; and delivering via the
treatment beam, a series of pulses onto the retinal tissue within
the first area as the treatment beam axis is scanned within the
first area, wherein the series of pulses are delivered for a
sufficiently short duration so as to avoid inducing traditional
photocoagulation of the retinal tissue while inducing
photoactivation of a therapeutic healing.
16. The method of claim 15, further comprising: delivering a first
series of pulses at a plurality of locations within the first area
during a first scan of the treatment beam axis within the first
area; and delivering at least one additional series of pulses at
each of the plurality of locations within the first area during a
second scan of the treatment beam axis within the first area.
17. The method of claim 15, further comprising: delivering via the
treatment beam, a first series of pulses at a first location within
the first area; and subsequent to delivering the first series of
pulses, delivering via the treatment beam, at least one additional
series of pulses at a second location within the first area.
18. The method of claim 15, wherein the duration of each pulse is
between about 5 microseconds and about 15 microseconds such that an
inner retinal temperature remains below a threshold of coagulative
damage.
19. The method of claim 15, further comprising delivering the
series of pulses with a specified interval between each pulse so as
to provide a predetermined spacing between pulse locations.
20. The method of claim 19, wherein the treatment boundary
comprises a treatment pattern having an array of geometric shapes,
and wherein the predetermined spacing is such that each of the
pulses is delivered within one of the geometric shapes.
21. A system for providing a therapeutic treatment to a patient's
eye, the system comprising: an aiming beam source configured to
transmit an aiming beam along an aiming beam path; a treatment beam
source configured to transmit a treatment beam along a treatment
beam path; a scanning device disposed along the aiming beam path
and the treatment beam path and configured to scan the aiming beam
and the treatment beam along a retina of the patient's eye; and a
processor coupled to the scanning device and configured to: direct
the aiming beam onto the retina to define a first treatment
position and a second treatment position; scan the treatment beam
between the first position and the second position while delivering
a series of pulses onto the tissue, wherein the series of pulses at
each position are of sufficiently short duration so as to avoid
inducing traditional photocoagulation of the tissue while inducing
photoactivation of a therapeutic healing to the tissue.
22. The system of claim 21, wherein the scanning device is disposed
within an adapter device that is removably couplable with an
ophthalmic measurement instrument and that is optically couplable
with the light beam source.
23. The system of claim 22, wherein the adapter device further
includes the aiming beam source.
Description
CROSS-REFERENCES TO RELATED APPLICATIONS
[0001] This application claims priority to Provisional U.S. Patent
Application No. 61/549,036 filed Oct. 19, 2011, entitled "Grid
Pattern Therapeutic Treatment," the entire disclosure of which is
hereby incorporated by reference, for all purposes, as if fully set
forth herein.
BACKGROUND
[0002] Therapeutic lasers are often used to treat various
conditions of the eye. For example, a specific type of condition
that may be treated with such lasers is diabetic retinopathy.
Diabetic retinopathy, is damage to the retina that is due to
complications of diabetes. If left untreated, diabetic retinopathy
can eventually lead to blindness. Diabetic retinopathy typically
results from microvascular retinal changes. For example, diabetic
induced effects may damage tissue of the eye, which may change the
formation of the blood-retinal barrier and make the retinal blood
vessels become more permeable. In treating such conditions, one or
more light beams may be directed into the eye and/or onto retinal
tissue to cause photocoagulation of the tissue so as to finely
cauterize ocular blood vessels and/or prevent blood vessel growth
to induce various therapeutic benefits. Laser photocoagulation is
commonly used for early stages of retinopathy.
[0003] In providing laser photocoagulation treatments, however, it
is important to avoid damaging sensitive tissue of the eye, such as
the fovea, macula, and the like. In certain instances, it may be
desired to treat tissue close to one or more of these areas while
ensuring that damage to such areas is avoided. Conventional laser
photocoagulation techniques do not offer optimal solutions to
treating areas close to such sensitive tissue while ensuring that
damage to such tissue will be avoided or greatly reduced.
Accordingly, there is a need in the art for improved laser
photocoagulation methods for treating various conditions of the
eye, such as diabetic retinopathy.
SUMMARY OF THE INVENTION
[0004] Embodiments of the invention described herein provide
systems and methods for treating retina tissue and/or other areas
of a patient's eye. The procedures may involve using one or more
light beams (e.g., lasers) to cause photocoagulation to finely
cauterize ocular blood vessels and/or prevent blood vessel growth
to induce one or more therapeutic benefits. Such procedures may be
used to treat diabetic retinopathy, macular edema, and/or other
conditions of the eye. According to one aspect, a method for
treating an eye of a patient is provided. The method may include
directing an aiming beam onto retinal tissue of the patient's eye
and defining (e.g., via the aiming beam) a first target position
and a second target position. The method may also include
delivering (e.g., via a treatment beam) a series of pulses onto the
retinal tissue at the first and second target positions to treat
the retinal tissue. A duration of each pulse may be sufficiently
short so as to avoid inducing traditional photocoagulation of the
retinal tissue, but may be sufficient to induce photoactivation of
a therapeutic healing at some or each position.
[0005] According to some embodiments, the treatment beam may scan
between the locations between the each pulse. According to another
embodiment, the treatment beam may deliver a first series of pulses
at the first target position before moving to the second target
position to deliver a second series of pulses. According to some
embodiments, the treatment beam may have an oval or oblong cross
section that is configured to produce more circular incident light
profiles on the retinal tissue as the treatment beam axis is
scanned across the retinal tissue and the series of pulses are
delivered. For example, the incident light profiles may be more
circular than incident light profiles produced with circular cross
section treatment beams.
[0006] According to some embodiments, the method may further
include scanning the treatment beam from the first target position
to the second target position within a first area identified by the
aiming beam and delivering the series of pulses between the first
target position and the second target position so that each pulse
is delivered at a different position between the first position and
the second position. According to some embodiments, the method may
additionally include rescanning the treatment beam from the first
target position to the second target position within the first area
and delivering an additional series of pulses between the first
target position and the second target position at approximately the
same positions as the previous series of pulses were delivered. In
some embodiments, this scan and rescan process may each comprise a
treatment cycle and the process may be repeated to provide between
about 10 and about 10,000 treatment cycles to treat the retinal
tissue of the eye within the first area.
[0007] In some embodiments, at least 9 pulses or more may be
delivered between the first target position and the second target
position. Similarly, the scan from the first target position to the
second target position may be completed in a scan time of between
about 0.5 milliseconds and about 1.5 milliseconds. In another
embodiment, the scan from the first target position to the second
target position may be completed in a scan time of between about
0.9 milliseconds and about 1.1 milliseconds. The scan of the
treatment beam axis may follow a raster scan pattern.
[0008] According to some embodiments, the duration of each pulse
may be sufficiently short so that an inner retinal temperature
remains below a threshold of coagulative damage. The duration of
each pulse may be between about 5 microseconds and about 15
microseconds, or in another embodiment, may be between about 9
microseconds and about 11 microseconds.
[0009] According to another aspect, a method for treating an eye of
a patient is provided. The method may include directing an aiming
beam onto retinal tissue of the patient's eye and defining (e.g.,
via the aiming beam) a treatment boundary separating the retinal
tissue to a first area and a second area. The method may also
include scanning an axis of a treatment beam within the first area
and delivering (e.g., via the treatment beam) a series of pulses
onto the retinal tissue within the first area as the treatment beam
axis is scanned within the first area. The series of pulses may be
delivered for a sufficiently short duration so as to avoid inducing
traditional photocoagulation of the retinal tissue while inducing
photoactivation of a therapeutic healing.
[0010] According to some embodiments, the method may further
include delivering a first series of pulses at a plurality of
locations within the first area during a first scan of the
treatment beam axis within the first area and delivering at least
one additional series of pulses at each of the plurality of
locations within the first area during a second scan of the
treatment beam axis within the first area. According to another
embodiment, the method may further include delivering (e.g., via
the treatment beam) a first series of pulses at a first location
within the first area and subsequent to delivering the first series
of pulses, delivering (e.g., via the treatment beam) at least one
additional series of pulses at a second location within the first
area.
[0011] According to one embodiment, the duration of each pulse may
be between about 5 microseconds and about 15 microseconds such that
an inner retinal temperature remains below a threshold of
coagulative damage. According to one embodiment, the method may
additionally include delivering the series of pulses with a
specified interval between each pulse so as to provide a
predetermined spacing between pulse locations. In such embodiments,
the treatment boundary may include a treatment pattern having an
array of geometric shapes and the predetermined spacing may be such
that each of the pulses is delivered within one of the geometric
shapes.
[0012] According to another aspect, a system for providing a
therapeutic treatment to a patient's eye is provided. The system
may include, among other things, an aiming beam source, a treatment
beam source, a scanning device, and a processor. The aiming beam
source may be configured to transmit an aiming beam along an aiming
beam path. The treatment beam source may be configured to transmit
a treatment beam along a treatment beam path. The scanning device
may be disposed along the aiming beam path and the treatment beam
path and may be configured to scan the aiming beam and the
treatment beam along a retina of the patient's eye. The processor
may be coupled to the scanning device and may be configured to:
direct the aiming beam onto the retina to define a first treatment
position and a second treatment position and scan the treatment
beam between the first position and the second position while
delivering a series of pulses onto the tissue. The series of pulses
at each position may be of sufficiently short duration so as to
avoid inducing traditional photocoagulation of the tissue while
inducing photoactivation of a therapeutic healing to the
tissue.
[0013] According to some embodiments, the scanning device may be
disposed within an adapter device that is removably couplable with
an ophthalmic measurement instrument and that is optically
couplable with the light beam source. The adapter device may
receive a light beam from the light beam source and direct the
light beam onto retinal or other tissue of the patient's eye. In
some embodiments, the adapter device may also include the aiming
beam source.
BRIEF DESCRIPTION OF THE DRAWINGS
[0014] The present invention is described in conjunction with the
appended figures:
[0015] FIGS. 1A-1G illustrate various perspective view of an
adapter that may be coupled with an ophthalmic imaging instrument
to enable the ophthalmic imaging instrument to provide a boundary
defined therapeutic treatment.
[0016] FIGS. 2A-2E illustrate various views of the adapter of FIGS.
1A-1G coupled with an ophthalmic imaging instrument.
[0017] FIG. 3 illustrates a block diagram of a system for providing
therapeutic treatments in accordance with an embodiment of the
invention.
[0018] FIGS. 4A-4C illustrate block diagrams of a display interface
that may be used with the system of FIG. 3.
[0019] FIGS. 5A-5F illustrate various treatment boundaries and/or
treatment patterns that may be used for the boundary defined
therapeutic treatments.
[0020] FIGS. 6A-6F illustrate laser light being delivered within or
with respect to the treatment boundaries and/or treatment patterns
of FIGS. 5A-5F.
[0021] FIGS. 7A-7F illustrate a process of sequentially delivering
laser light within a treatment pattern.
[0022] FIG. 8 illustrates a treatment pattern being positioned
adjacent a feature or tissue of a patient's retina.
[0023] FIGS. 9A-9C illustrate an oblong or oval cross sectional
profile of a treatment laser that may be used to compensate for
continuous movement of the treatment laser during a treatment
procedure.
[0024] FIGS. 10A-10C illustrate a retinal image, profile, or map
that may be used in a therapeutic treatment procedure.
[0025] In the appended figures, similar components and/or features
may have the same numerical reference label. Further, various
components of the same type may be distinguished by following the
reference label by a letter that distinguishes among the similar
components and/or features. If only the first numerical reference
label is used in the specification, the description is applicable
to any one of the similar components and/or features having the
same first numerical reference label irrespective of the letter
suffix.
DETAILED DESCRIPTION OF THE INVENTION
[0026] The ensuing description provides exemplary embodiments only,
and is not intended to limit the scope, applicability or
configuration of the disclosure. Rather, the ensuing description of
the exemplary embodiments will provide those skilled in the art
with an enabling description for implementing one or more exemplary
embodiments. It should be understood that various changes may be
made in the function and arrangement of elements without departing
from the spirit and scope of the invention as set forth in the
appended claims.
[0027] Embodiments of the invention provide systems and methods for
treating the retina and/or other areas of a patient's eye. The
procedures may involve using one or more light beams (e.g., lasers)
to cause photocoagulation to finely cauterize ocular blood vessels
and/or prevent blood vessel growth to induce one or more
therapeutic benefits. Such procedures may be used to treat diabetic
retinopathy, macular edema, and/or other conditions of the eye. In
some embodiments, photocoagulation may result in a series of
visible spots that appear in the retina. In other embodiments, a
series of short duration light pulses (e.g., between 5-15
microseconds) may be delivered to the retinal tissue with a thermal
relaxation time delay between each pulse to limit the temperature
rise of the target retinal tissue and thereby limit a thermal
effect to only the retinal pigment epithelial layer. Such short
duration pulses (also referred to herein as micropulses) may not
result in visible spots that appear on the retina and may result in
less overall tissue damage.
[0028] The treatment light (i.e., laser light) delivered to treat
and/or coagulate the retinal tissue may be delivered at therapeutic
levels within a defined treatment boundary that may include a
pattern of recurring geometric shapes. The treatment boundary may
define an area within which treatment light at therapeutic levels
is directed and outside of which treatment light is substantially
not directed or is provided at sub-therapeutic levels, such as in
the case of refracted light, incident light, and the like. Thus,
the treatment boundary may define an area within which therapeutic
treatment is provided and outside of which therapeutic treatment is
not provided or minimally provided. The treatment boundary and/or
pattern may be projected and/or defined on the retinal surface of
the patient's eye to display the area to be treated. Because the
treatment boundary may define or distinguish the area of the retina
that does not receive or minimally receives the therapeutic
treatment, a peripheral edge of the treatment boundary may be
positioned adjacent sensitive tissue of the retina and/or anywhere
that the therapeutic treatment is not desired to ensure that the
sensitive tissue or area will not receive or will minimally receive
the therapeutic treatment. It should be realized that some
therapeutic light may be incident upon tissue outside of the
treatment boundary due to refraction, light scattering, and the
like, but such light will be minimal and likely have minimal effect
upon the tissue outside of the treatment boundary. Thus,
embodiments of the invention provide precise controls for
determining areas of the retina that will receive therapeutic
treatment and areas that will not.
[0029] The peripheral edge of the treatment boundary, along with
the remainder of the treatment boundary, may be defined and
displayed on a user interface, map or image of the retina, and/or
on the retina itself so that a physician or user providing the
therapeutic treatment is aware of the outer boundary of the
treatment area. Since the outer boundary of the treatment area is
displayed, the physician may closely abut or place the treatment
area proximate to sensitive tissue and/or to any other area while
ensuring that the sensitive tissue or other area will not be
treated or minimally treated.
[0030] In some embodiments, a treatment pattern includes an array
of aiming spots instead of, or in addition to, an enclosed boundary
or pattern. The array of aiming spots may be defined on the
patient's retina as described herein and the treatment beam may be
fired or delivered coaxially with respect to one or more of the
aiming spots.
[0031] The treatment boundary and/or treatment pattern may be
defined and/or projected on the retinal surface using one or more
aiming beams. The aiming beam may be a laser beam or any other type
of light beam (e.g., a beam produced by a high powered light
emitting diode (LED)). The aiming beam may be generally referred to
herein as an aiming laser, although it should be realized that
light beams other than lasers may be used. The aiming beam may be a
low intensity laserlight beam that does not damage the retinal
tissue. In some embodiments, the aiming beam has a wavelength of
between about 600 nm (nanometers) and about 700 nm, and more
commonly about 650 nm. The aiming beam may be provided by a laser
diode and may have an incident spot or cross section on the retinal
tissue that is substantially smaller than an incident spot of the
treatment laser that is used to treat the retinal tissue.
Alternatively, in some embodiments, the aiming beam may be provided
by a high powered light emitting diode (LED) in place of, or in
addition, to the aiming laser. The aiming beam may be scanned on
the patient's retina, or on a display interface or image of the
retina, to trace or outline the treatment boundary and/or treatment
pattern so as to visually display the treatment boundary and/or
pattern to a physician. The treatment boundary and/or pattern
defined or projected onto the retinal surface may be captured by a
camera and displayed to the physician or other user on a display
interface.
[0032] One or more treatment beam pulses or doses may be delivered
within the treatment boundary and/or pattern to treat the retinal
tissue. The treatment beam may be generally referred to herein as a
treatment laser, although, like the aiming beam, it should be
realized that other light beams may be used, such as a high
intensity light beam from a high powered light emitting diode
(LED). The treatment pulses or doses may be delivered as a scanning
device continuously scans an axis of the treatment beam within the
treatment boundary and/or may be delivered as the scanning device
sequentially moves the treatment beam axis between specified
locations within the treatment boundary. In embodiments involving
treatment patterns having recurring geometric shapes, one or more
treatment beam pulses may be delivered within some or each of the
geometric shapes. In a specific embodiment, a single treatment beam
pulse may be delivered substantially in a geometric center of each
of the geometric shapes. A cross section of the incident beam light
(e.g., a laser beam spot) may be roughly equivalent in size with
the geometric shape. In some embodiments, the treatment beam (e.g.,
laser beam) may have a wavelength of between about 400 nm and 600
nm, and more commonly between about 520 nm and 560 nm.
[0033] The therapeutic treatment (also referred to herein as a
boundary defined therapeutic treatment) may be provided via an
adapter that is configured to be mounted onto and operate with a
preexisting ophthalmic imaging instrument, such as a slit lamp. The
adapter may also operate with a preexisting treatment beam source,
such as a laser delivery instrument. An external controller or
computer system may be communicatively coupled with the adapter and
laser delivery instrument to define the treatment boundary and/or
pattern on the retinal tissue and deliver the treatment beam within
the treatment boundary/pattern. The adapter and/or controller may
allow a preexisting slit lamp and laser delivery instrument to
provide the boundary defined therapeutic treatment described
herein, which slit lamp and laser delivery instrument would
otherwise be incapable of delivering.
[0034] Embodiments of the invention also describe methods and
system of using retinal imaging and/or tracking to provide a
therapeutic treatment (e.g., the boundary defined therapeutic
treatment) described herein or another therapeutic treatment. The
therapeutic treatment and/or a treatment boundary may be programmed
and/or documented with reference to a retinal image or model of a
patient's retina. A system performing the therapeutic treatment may
reference the retinal image or model and the programmed therapeutic
treatment or treatment boundary to determine a location or area of
the patient's retina to provide the therapeutic treatment. The
system may then automatically begin the therapeutic treatment or
display the treatment boundary/pattern and corresponding retina
treatment area to a physician for review, adjustment, and/or
authorization to proceed. A plurality of such therapeutic
treatments may be programmed into the system so that the system may
quickly and conveniently begin performing an additional therapeutic
treatment shortly after completing a current or previous treatment.
The provided treatments may be documented or recorded on the
retinal image or model for simultaneous or subsequent review by the
physician or user. For example, treatment spots or other indicia
may be superimposed on the retinal image for each location or
position that a pulse or dose of the treatment beam is received.
The superimposed spots or indicia may document the areas of the
retina for which therapeutic treatment was provided. This may be
particularly useful when no visible effects of the therapeutic
treatment are present on the retinal tissue, such as in micropulse
procedures.
[0035] Referencing the therapeutic treatment and/or treatment
boundary procedure with respect to the retinal image or model may
also allow the system to compensate for movement of the patient's
eye during the procedure. For example, retinal tracking may allow a
camera to capture substantially smooth images of the retina and/or
allow the system to adjust to a movement of the patient's eye and
continue to deliver the therapeutic treatment at substantially the
same location. Having briefly described some embodiments of the
invention, additional aspects will become apparent with reference
to the figures.
Embodiments of Therapeutic Treatment Hardware and Components
[0036] FIGS. 1A-1G illustrate perspective views of an embodiment of
an adapter that may be coupled with an ophthalmic imaging
instrument, such as a slit lamp, to adapt the ophthalmic imaging
instrument to provide the boundary defined therapeutic treatment
described herein. FIGS. 2A-2E illustrate the adapter 100 coupled
with a slit lamp 200. FIGS. 1A-1C provide various perspective views
of the adapter 100. FIGS. 1D-1G also provide perspective views of
adapter 100 with a front cover of the adapter removed to show
various components housed within adapter 100. Adapter 100 includes
a housing 102 having a front and back cover coupled together.
Adapter 100 also includes a mounting member 104 that releasably
couples adapter 100 with the ophthalmic imaging instrument (e.g.,
slit lamp 200). Adapter 100 also includes adapting component 105
that facilitates in coupling adapter 100 with the ophthalmic
imaging instrument 200. Component 105 may include a rotatable
mounting knob 103 that presses mounting member 104 firmly against a
mounting feature (not shown) of the ophthalmic imaging instrument.
Component 105 also includes a mirror 106 that reflects light
delivered from adapter 100 toward an eye of a patient and that may
be transparent or semi-transparent so that some light is delivered
back to a camera (e.g., camera 360) and/or binocular adapter 152
that couples with a binocular (e.g., binocular 210) or other
eyepiece. Component 105 may further include an adjuster bar 135
that allows rotational adjustment of adapter 100 and/or the
ophthalmic imaging instrument 200.
[0037] Adapter 100 further includes an interface or port 110 that
couples with a fiber optic cable of an external laser delivery
instrument (e.g., laser delivery instrument 310). The fiber optic
cable of the external laser delivery instrument provides or
delivers a treatment laser 112 to adapter 100. Adapter 100 includes
mirror 136 that reflects treatment laser 112 toward an aiming
device 130 (also referred to herein as a scanning device or
system). Mirror 136 may be a perforated mirror, half mirror,
dichroic mirror, and the like and may be mounted on a lens holder.
Aiming device 130 may be a galvanometer-based scanner (commonly
referred to as "galvos") manufactured by Cambridge Technology.RTM..
Aiming device 130 includes a pair of rotatable elements or mirrors,
132 and 134, mounted atop motors that rotate elements or mirrors,
132 and 134, about orthogonal axes. Each mirror, 132 and 134, may
provide 1-D beam deflection, so that the pair of mirrors provides
2-D beam deflection. Aiming device 130 is used to scan treatment
laser 112 and/or other lasers (e.g., aiming laser 122) relative to
the eye so that the lasers may be aimed and fired at desired
locations on or within the eye. For example, aiming device 130 may
be used to scan aiming laser 122 to define the treatment boundary
and/or treatment pattern on retinal tissue and to scan a beam of
treatment laser 112 within the treatment boundary/pattern so as to
provide the boundary defined therapeutic treatment.
[0038] Aiming laser 122 passes through mirror 136 to aiming device
130. In some embodiments, adapter 100 may include another interface
or port (not shown) that receives the aiming laser 122 from an
external laser delivery instrument or source (not shown), which may
be the same laser delivery instrument that delivers treatment laser
112 or a different unit. In other embodiments, adapter 100 includes
a laser delivery instrument or source 120 within housing 102. For
example, laser delivery instrument 120 may include a laser diode
124, or alternatively a high powered LED, that provides the aiming
laser 122. Laser delivery instrument 120 may also include a
computing device 126, such as a memory device and/or processor,
that is communicatively coupled with an external controller (e.g.,
controller 330 and/or 310) to control the delivery of aiming laser
122.
[0039] In one embodiment, aiming laser 122 may be provided along a
laser path substantially orthogonal to a laser path of treatment
laser 112. The laser paths of aiming laser 122 and treatment laser
112, however, may be aligned or substantially coaxial after aiming
laser 122 pass through mirror 136. For example, laser path 128
illustrates a path of a laser being delivered from aiming device
130 and reflected off mirror 106 toward an eye of a patient. Laser
path 128 may correspond to either or both aiming laser 122 and
treatment laser 112 since at this point the laser paths may be
coaxially aligned.
[0040] Aiming laser 122 may have a wavelength selected within the
visible spectrum to provide improved visibility of the treatment
boundary and/or pattern on the retina. For example, in some
embodiments, aiming laser 122 has a wavelength between about 600 nm
and about 700 nm, and more commonly about 650 nm. Aiming laser 122
may be a low intensity beam that does not damage retinal and/or
other tissue of the eye. Aiming laser 122 may also have an incident
spot or cross section that is substantially smaller than an
incident spot of treatment laser 112. In some embodiments,
treatment laser 112 may also have a wavelength selected within the
visible spectrum, although non-visible wavelengths may also be
used. In a specific embodiment, treatment laser 112 has a
wavelength of between about 400 nm and 600 nm, and more commonly
between about 520 nm and 560 nm. Treatment laser 112 may be used to
coagulate retinal and/or other tissue of the eye and/or provide
other therapeutic healing.
[0041] Adapter 100 also include a magnification mechanism 140 that
may be used to increase the cross section or incident spot of the
treatment laser 112 and/or aiming laser 122. Magnification
mechanism 140 is positioned along a laser path (e.g., laser path
128) distally of aiming device 130. Magnification mechanism 140
includes a plurality of lenses 142 mounted on a rotatable lens
holder 144. Each lens has a specified optic power that increases or
decreases the cross section or incident spot of the treatment laser
112 and/or aiming laser 122. Lens holder 144 may be rotated so that
a desired lens is positioned along laser path 128. In some
embodiments, lens holder 144 is rotated by rotating a control knob
146 positioned on an exterior surface of housing 102, although in
some embodiments, lens holder 144 may be rotated
electronically.
[0042] FIGS. 2A-2E illustrate various perspective views of adapter
100 mounted with slit lamp 200, which may be any slit lamp commonly
used, such as those manufactured by Haag-Streit International.RTM.,
Carl Zeiss.RTM., and the like. Slit lamp 200 includes binoculars
210 that provide a stereoscopic view of the patient's eye.
Binoculars 210 may be coupled with binocular adapter 152. Slit lamp
200 also includes a patient mounting frame 220 having vertical
frame members 222, a chin rest 224, and head rest 226. Although not
shown, slit lamp 200 may also include a joystick and foot pedal
that may be used to provide functional control of various slit lamp
components and/or operations and/or to deliver the therapeutic
treatment beam. Slit lamp 200 and/or chin rest 224 may be
vertically adjusted to accommodate patients of different size.
[0043] FIG. 3 illustrates embodiments of various controls that may
be used to provide the therapeutic treatments described herein.
Specifically, FIG. 3 illustrates adapter 100 coupled with an
external laser delivery instrument 310 via optical fiber 324.
Optical fiber 324 connects to port 110 and delivers treatment laser
112 to adapter 100. Optical fiber 324 may be coupled with one of a
plurality of optical fiber ports 322 on laser delivery instrument
or source 310. The optical fiber ports 322 may allow two optical
fibers 324 to be connected to laser delivery instrument 310. Laser
delivery instrument 310 also includes a display interface 320
(e.g., a touch screen interface) that displays settings and
controls for the therapeutic treatment to be provided as shown in
FIGS. 4A-4C. Laser delivery instrument 310 may also include a
remote control unit 326 (wireless or wired) that allows a user to
remotely operate and adjust various settings of the laser delivery
instrument. Likewise, laser delivery instrument 310 may include a
foot pedal 340 that is operated to perform the therapeutic
treatment and/or deliver treatment laser 112. Foot pedal 340 may be
wirelessly coupled with laser delivery instrument 310. Examples of
laser delivery instrument 310 include the IQ 532, IQ 577, Oculight
TX, and the like, manufactured by IRIDEX Corp.RTM..
[0044] Laser delivery instrument 310 may be a conventional unit
that is not able to offer the boundary defined therapeutic
treatment in its conventional state. To enable the laser delivery
instrument 310 to provide this treatment, a computer system 330 may
be communicatively coupled with laser delivery instrument 310
and/or adapter 100. Computer system 330 may be a separate set top
box that plugs into one or more ports of the laser delivery
instrument 310 to communicate with laser delivery instrument 310.
Additionally, computer system 330 may include one or more
processors and memory devices that allow computer system 330 to
interface with various other systems or units to perform the
therapeutic treatment. Information may be routed between computer
system 330 and a computer system or processor of laser delivery
instrument 310 so that computer system 330 controls the delivery of
treatment laser 112 and graphical displays information to a user
via display interface 320. For example, computer system 330 may
interface with the controls of laser delivery instrument 310 (e.g.,
touch screen controls, remote control 326, foot pedal 340, and the
like) so that adjustment of the controls of laser delivery
instrument 310 configure or adjust the settings and parameters of
computer system 330. As shown in FIGS. 4A-4C, computer system 330
may control display interface 320 to display various setting and/or
operations of the boundary therapeutic treatment, such as the
shape, orientation, scale, geometric pattern, laser intensity and
the like, of the specific treatment boundary/pattern being
projected. Computer system 330 may control (via one or more
instructions) laser delivery instrument 310 to delivery treatment
laser 112 doses at specified points and at specified times. For
example, computer system 330 may control laser delivery instrument
310 so that treatment laser 112 beams or doses are delivered within
the defined treatment boundary, treatment pattern, and/or defined
geometric shapes as described below. Likewise, computer system 330
may control laser delivery instrument 310 so that the delivered
treatment laser 112 coagulates the retinal tissue of the eye or
provides a less traumatic series of short duration pulses (e.g.,
micropulses) with a defined relaxation interval between pulses as
described below.
[0045] In essence, computer system 330 may be communicatively
coupled with laser delivery instrument 310 so that laser delivery
instrument 310 functions as a pass through input and interface
device for computer system 330 to enable a physician or user to
interface with computer system 330 and adjust various parameters of
the therapeutic treatment. Computer system 330 also functions with
the preexisting controls of laser delivery instrument 310 (e.g.,
foot pedal 340, internal hardware components, and the like) to
deliver treatment laser 112 to adapter 100.
[0046] Computer system 330 is also communicatively coupled with
adapter 100 to perform various aiming or other functions. For
example, computer system 330 may control aiming or scanning device
130 and/or laser delivery instrument 120 to aim or scan treatment
laser 112 and aiming laser 122 onto specified areas of the retina.
Computer system 330 may interleave treatment laser 112 and aiming
laser 122 during the therapeutic treatment procedure. Computing
device 330 controls the delivery of aiming laser 122 and controls
scanning device 130 to define or project the treatment boundary or
treatment pattern onto the retina.
[0047] In some embodiments, control unit 330 switches aiming laser
122 on while treatment laser 112 is switched off to define the
treatment boundary. Control unit 330 then switches aiming laser 122
off while treatment laser 112 is fired at target tissue within the
treatment boundary. Between subsequent firings of treatment laser
112, control unit 330 may switch aiming laser 122 on to redefine or
project the treatment boundary or pattern on the retina. As shown
in FIGS. 7A-7F, the resulting visual effect to an observer may be
the nearly continuous appearance of the treatment boundary or
pattern on the retina while treatment spots from the treatment
laser are sequentially fired and observed on target tissue within
the treatment boundary or pattern. In some embodiments, such as the
delivery of micropulses, the aiming device 130 may be continuously
scanned while treatment laser 112 is fired within the treatment
boundary.
[0048] Although shown as separate units, in some embodiments, laser
delivery instrument 310 and computer system 330 are combined into a
single unit so that substantially all the controls and operations
are provided from a single unit. Further, as described in more
detail below, computer system 330 may be coupled with a camera 360
(e.g., CCD camera and the like) to provide the retinal imaging and
tracking features described below as well as to display the
treatment boundary and/or pattern on a display device, such as
display interface 320.
[0049] Computer system 330 may comprise hardware and/or software,
often including one or more programmable processor units running
machine readable program instructions or code for implementing some
or all of one or more of the methods described herein. The code
will often be embodied in a tangible media such as a memory
(optionally a read only memory, a random access memory, a
non-volatile memory, or the like) and/or a recording media (such as
a floppy disk, a hard drive, a CD, a DVD, a memory stick, or the
like).
[0050] FIGS. 4A-4C illustrate various displays that may be
displayed on display interface 320. Display 410 is shown displaying
a treatment pattern 406 that includes a square grid of nine
treatment areas or locations within which therapeutic light will be
delivered onto retinal tissue via treatment laser 112. The grid may
be adjusted using controls 404 so that the grid includes a
3.times.3 array of treatments boxes or locations, a 4.times.4 array
of treatment locations, a 5.times.5 array of treatment locations,
or a user defined array of treatment locations. Display 410 also
includes controls 402A-402C that may be used to set or adjust
various settings, controls, and/or parameters. For example, control
402A may be used to control a spacing between center points of
treatment spots that will be delivered within each of the treatment
locations, or stated differently, define a scale of the treatment
pattern. Control 402B may be used to control an orientation of the
array of treatment locations with respect to the retina. Control
402C may be used to control an arc and/or radius of curvature of
the array, if desired. FIG. 4A shows treatment pattern 406 without
an arc and radius of curvature. FIG. 4C shows display 430 having an
arched or curved treatment pattern 436 including three rows and six
columns of treatment spots. Treatment pattern 436 includes an arc
(e.g., 360.degree.) and radius of curvature (e.g., 2000
micrometers) that are non-zero so that treatment pattern 436 is
curved. Display 430 similar includes control buttons 432A-432C and
434. FIG. 4B shows a display 420 that may be used to adjust or set
various parameters of the treatment laser 112 and/or aiming laser
122. For example, controls of display 420, which may include touch
screen controls, may be used to adjust a duration 422 (e.g., in
microsecond intervals) that the treatment laser 112 is fired,
adjust a power level 424 (e.g., in microwatts) of the treatment
laser 112, and adjust an interval 426 (e.g., in microseconds)
between sequential treatment laser firings.
[0051] Display 420 may be used to adjust the treatment laser 112
between traditional photocoagulating procedures and micropulse
procedures. Display 420 may also include other controls 428, such
as a control that selects a port (e.g., 322) to which optic fiber
324 will connect. As described above, the controls of the display
320 may be touch screen controls or may include rotatable or
selectable tabs or buttons.
Embodiments of Treatment Boundaries and/or Patterns
[0052] FIGS. 5A-5F show various embodiments of treatment boundaries
and/or patterns that may be used for the therapeutic treatments
described herein. These treatments boundaries/patterns may be
projected or defined on the patient's retina via aiming or scanning
laser 122. The projected or defined boundaries or patterns may be
captured by a camera and displayed to a user or physician on a
display device, such as display interface 320. The treatment
boundaries/patterns define an area within which the therapeutic
treatment is provided and outside of which the therapeutic
treatment is not provided. One advantage of the treatment boundary
process described herein is that the boundaries of the treatment
area are clearly defined, which allows the physician or user to
precisely know or determine where the therapeutic treatment will
and will not be provided.
[0053] FIG. 5A shows a square or rectangular treatment boundary 510
enclosing a single treatment area 512 within which one or more
treatment laser pulses or doses may be fired. FIG. 5B shows a
treatment pattern 520 including a grid or array of a plurality of
equally sized treatment squares or rectangles 522. Treatment
pattern 520 is defined by peripheral edges 526 and internal lines
526. FIG. 5B shows a 3.times.3 array, although any M.times.N array
may be used. FIG. 5C shows an arched or curved treatment pattern
530 including an array of a plurality of four sided geometric
shapes 532. Each shape 532 includes opposing linear sides 536 and
opposing arcuate sides 534. Treatment pattern 530 may have a radius
of curvature and liner opposing sides 536 may each project radially
from a center point. FIG. 5D shows a treatment pattern 540 having a
plurality of hexagonal shapes 542 arranged in a honeycomb pattern.
FIG. 5E shows a treatment pattern 550 having a square or
rectangular array of aiming spots 552 that define locations where a
treatment laser pulse or dose will be delivered. FIG. 5F shows a
treatment pattern 560 having a semicircular array of aiming spots
562 that define locations where a treatment laser pulse or dose
will be delivered.
[0054] The treatment boundaries, patterns, and/or geometric shapes
may be projected or defined on the retina by controlling a position
of the aiming laser (e.g., aiming laser 122) via scanning or aiming
device, so that the aiming laser outlines or defines the treatment
boundaries, patterns, and/or geometric shapes on retinal tissue
and/or displays the treatment pattern on a display device or
interface. The position of the aiming laser may be adjusted between
each of a plurality of pulses to define or outline the treatment
boundaries, patterns, and/or geometric shapes on the retina. The
resulting visual effect may be a solid, semi-solid, or pulsing
treatment boundary, pattern, and/or geometric shapes defined on the
retina as shown in FIGS. 5A-5D.
[0055] It should be realized that FIGS. 5A-5D are for illustrative
purposes only and that the treatment boundary/pattern may include
various other arrays of geometric shapes, which may or may not
include recurring patterns.
[0056] FIGS. 6A-6F show treatment spots representing the treatment
laser being fired or delivered within the treatment boundaries or
patterns or delivered coaxially therewith. The treatment spots may
represent visible tissue damage that occurs when the treatment
laser is fired, such as in traditional photocoagulation procedures,
or may represent a location where the treatment laser is fired even
though no tissue damage is visible, such as in micropulse
procedures. FIG. 6A illustrates a plurality of treatment spots 612,
which represents locations within treatment boundary 510 where the
treatment laser (e.g., treatment laser 112) was or is to be fired.
Similarly, FIG. 6B illustrates treatment spots 622 being fired
within each treatment square or rectangle 522 of treatment pattern
520. FIG. 6C illustrates treatment spots 632 being fired
substantially within a center of each geometric shape 532 of
treatment pattern 530 and FIG. 6D illustrates treatment spots 642
being fired within a substantial center of each hexagonal shape 542
of treatment pattern 540. FIG. 6C illustrates embodiments where
arcuate therapeutic treatments are provided and FIG. 6D illustrate
embodiments where the treatment spots are more tightly or closely
spaced. The treatment spots of FIG. 6D may overlap with treatment
spots in adjacent rows and/or columns. FIGS. 6E and 6F illustrate
treatment spots 652 and 662 being delivered substantially coaxially
with respect to aiming spots 552 and 562 of treatment patterns 550
and 560 respectively. In another embodiment, larger circles 652 and
662 may represent the defined treatment patterns and smaller spots
552 and 562 may represent the therapeutic laser fired or delivered
within a substantial center of each treatment pattern. Such
embodiments illustrate that the defined treatment patterns or
boundaries need not have adjacent geometric shapes that touch.
Rather, some or all of the geometric shapes may be isolated from
one or more adjacent geometric shapes.
[0057] Although FIGS. 6B-6D show a single treatment spot being
delivered within each of the geometric shapes, in some embodiments
multiple spots (e.g., 2, 3, 4, or more) may be delivered within one
or more of the geometric shapes. Similarly, the number of treatment
spots delivered within each geometric shape may be varied to
provide additional therapeutic treatment flexibility.
[0058] FIG. 8 illustrates a treatment pattern or boundary 810 being
positioned adjacent tissue 820 of the retina for which a
therapeutic treatment is not desired. Treatment pattern 810 is
positioned adjacent tissue 820 so that tissue 820 is outside of the
treatment pattern or boundary. Tissue 820 may be sensitive tissue,
a feature of the eye (e.g., fovea, macula, and the like), and/or
any other tissue for which the therapeutic treatment is not
desired. As described above, treatment pattern 810 may be projected
or defined on the retina so that a physician or user may position
an outer edge or periphery of treatment pattern 810 adjacent tissue
820. The projection or definition of treatment pattern 810 on the
retina allows the physician or user to position the treatment
pattern as close to or distant from tissue 820 as desired while
ensuring that tissue 820 is not treated. As also shown in FIG. 8,
the therapeutic treatment (i.e., treatment spots 830) is confined
within treatment pattern 810 to ensure that tissue 820 does not
receive the therapeutic treatment. The shape of treatment pattern
810 and/or parameters of treatment pattern 810 (e.g., spacing,
radius, row or column number, and the like) may be changed to
accommodate various features of the eye. For example, the
semi-circular pattern of FIG. 5C may be used encircle a portion of
tissue 820 or the fovea. Likewise, the honeycomb pattern of FIG. 5D
may be used to tightly pack treatment spots within the treatment
area.
Embodiments of Therapeutic Treatment Procedures
[0059] In some embodiments, the treatment laser may be fired
substantially within a geometric center of each of the geometric
shapes as is shown in FIGS. 6B-6D. The treatment spot size of the
treatment laser incident on the retina may be substantially
equivalent in size or slightly smaller than the geometric shape.
Further, as previously described, the aiming laser may be switched
off during firing of the treatment laser and the treatment laser
may be switched off when the aiming beam defines or outlines the
treatment boundary or pattern.
[0060] The therapeutic treatment pulses or doses (e.g., the spots
shown in FIG. 6A-6D) may be delivered during a continuous scan of
the treatment laser beam (or more appropriately an axis of the
treatment laser beam) through the treatment boundary or pattern, or
the treatment laser beam may be sequentially moved to each target
site and the treatment laser fired while the treatment laser is
temporarily stopped. Continuous scan procedures may be particularly
useful for mircropulse procedures to minimize start and stop times
associated with the treatment laser and thereby minimize an overall
procedure time. The treatment laser beam (i.e., an axis of the
treatment laser) may be continuously scanned row by row and/or
column by column through the treatment boundary/pattern (e.g.,
similar to a raster scan pattern) until the treatment laser beam
reaches a designated end point and/or scans the entire treatment
boundary or pattern. The treatment laser may be sequentially or
repeatedly fired for a defined duration during the continuous scan
as the treatment laser nears each specified target site. The
treatment laser beam may be repositioned at a starting point of the
scan and the continuous scan and firing process may be repeated so
that additional therapeutic treatment is provided to some or all of
the previously treated retinal tissue (e.g., additional therapeutic
treatment is provided at some or each target site). In another
embodiment, the treatment laser may be stopped or paused at each
treatment location and a treatment laser beam repeatedly fired at
the treatment location until a sufficient treatment is
provided.
[0061] In micropulse procedures, the interval between therapeutic
treatment pulses or doses at the same target site may be
sufficiently long so that the retinal tissue being treated
sufficiently relaxes and a temperature of the tissue remains below
a threshold of coagulative damage, thereby minimizing tissue
damage. The thermal effect of the micropulse procedure may be
confined only to the retinal pigment epithelial layer. In some
embodiments, this relaxation interval, or thermal relaxation time
delay, may be about 190 microseconds or longer. Likewise, in some
embodiments, the firing duration of the treatment laser (i.e., the
treatment pulse or dose duration) is between about 5 and 15
microsecond, and more commonly about 10 microseconds.
[0062] Each scan and firing process (i.e., between defined start
and end points) may constitute a cycle of a micropulse procedure.
The micropulse procedure may involve between about 10 and 10,000
cycles. In some embodiments, the treatments laser is fired at 9 or
more treatment sites during each cycle of the scan and each
micropulse cycle is completed in between about 0.5 and 1.5
milliseconds, and more commonly about 1 millisecond, although it
should be realized that the treatment laser may be fired at any
number of treatment sites and the each cycle may include a shorter
or longer cycle duration. Further, a therapeutic treatment
procedure for a given treatment boundary/pattern may involve a
single continuous scan or several continuous scans each having
different start and end points.
[0063] In an alternative embodiment, the treatment laser may be
sequentially positioned at each target site and a series of
micropulses may be delivered at that target site before moving to
the next treatment site. Each pulse may be fired for a specified
duration (e.g., between about 5 and 15 microsecond, and more
commonly about 10 microseconds) and may have a sufficiently long
relaxation interval (e.g., about 190 microseconds or longer) so
that the retinal tissue at the treatment site sufficiently relaxes
and a temperature of the tissue remains below a coagulation
temperature, thereby minimizing tissue damage. The short duration
pulses may be sufficient to induce or provide photoactivation of a
therapeutic healing as is commonly known in micropulse procedures.
The former micropulse embodiment provides the advantage of allowing
the treatment laser to be fired at other treatment sites during the
relaxation interval, thereby minimizing an overall treatment
time.
[0064] The micropulse procedure may also include delivering the
series of pulses as the treatment laser beam (i.e., the axis of the
treatment laser) is continuously scanned with a specified time
interval between each laser pulse or dose so as to provide a
predetermined spacing between adjacent treatment spots. Such
procedures may be beneficial when a treatment pattern having an
array of geometric shapes, such as those shown in FIGS. 5B-5D is
used and/or when an array of aiming spots, such as those shown in
FIGS. 5E and 5F is used. The specified time interval and resulting
spacing may be such that each pulse is delivered within one of the
geometric shapes, substantially within a geometric center of each
shape, and/or over one or more of the aiming spots.
[0065] A therapeutic treatment procedure may involve delivering
therapeutic treatment to one area of the retina and then
subsequently delivering therapeutic treatment to one or more other
areas of the retina. For example, the aiming device (e.g., aiming
device 130) may define a first treatment boundary or pattern on a
first area of the retina and deliver therapeutic treatment within
the defined first treatment boundary or pattern and then
subsequently define a second treatment boundary or pattern (i.e.,
either the same or a different boundary/pattern) on a second area
of the retina and deliver therapeutic treatment within the defined
second treatment boundary or pattern. This process may be repeated
as often as desired to provide the therapeutic treatment.
[0066] FIG. 9A illustrates an elongated treatment spot 900
resulting from firing the treatment laser during a continuous scan
process. The treatment spot of the treatment laser corresponding to
FIG. 9A may have a substantially circular cross section. The
elongated spot may occur because the treatment laser is continually
moving during the firing process. As such, even though the
micropulse firing duration is short (e.g., approximately 10
microseconds), some elongation may occur due to the continuous
movement of the treatment laser. To minimize the effects of the
continuously moving treatment laser, the cross section of the
treatment spot incident on the tissue may be oval or oblong in a
direction orthogonal to the treatment laser path as shown in FIG.
9B. A shown in FIG. 9C, the oval or oblong treatment spot 910 may
facilitate in producing more circular treatment spots 930 or
incident light profiles on the retina as the treatment laser beam,
or more appropriately the axis of the treatment laser beam, is
scanned across the retina and the series of pulses delivered.
Embodiments of Retinal Mapping/Tracking
[0067] FIGS. 10A-10C illustrate embodiments involving retinal maps,
profiles, or images that may be used in therapeutic treatment
processes, such as those described herein. FIG. 10A shows a retinal
map or image 1000 of a patient's retina that may be captured using
one or more cameras (e.g., camera 360) of a slit lamp or other
ophthalmic imaging instrument. As described above, computer system
330 may be communicatively coupled with camera 360 to provide
retinal mapping, imaging, and/or tracking. Computer system 330 may
have a measurement device capable of generating images 1000 of the
retina 1012 and of providing information helpful for determining a
treatment area or areas and/or treatment pattern or patterns to
treat with the therapeutic treatment. A beam, such as treatment
beam 112 may be directed toward a treatment area of the retina by
referencing retinal image 1000. The beam may provide the
therapeutic treatment. Indicia, such as treatment spots, may be
superimposed on retinal image 1000 at a location corresponding to
the treatment area to document or record the therapeutic treatment
provided. For example, treatment spots or other indicia may be
superimposed on retinal image 1000 at each location that the beam
is fired. The plurality of superimposed treatments spots may
display the therapeutic treatment provided. The beam may then be
repositioned to another treatment area of the retina by referencing
the retinal image and a second therapeutic treatment provided
and/or documented with superimposed treatment spots in the manner
described above.
[0068] In some embodiments, a treatment area, boundary, and/or
pattern 1020 may be referenced to the image 1000, so that a
relationship between the location of the treatment area, boundary,
and/or pattern 1020 and the image 1000 data can be established. The
treatment area, boundary, and/or pattern 1020 may be linked to a
feature or reference location 1010 on the retina 1012, which can be
identified in the image 1000, such as a various veins, arteries,
the optic disc, macula, retinal landmarks or features, and the
like. Along with locating and/or determining the treatment area,
boundary, and/or pattern 1020, the measurement device (e.g.,
computer system 330) may also include at least a portion of a
processor system capable of calculating a set of treatment
instructions to be used by a therapeutic treatment deliver system,
such as adapter 100 and slit lamp 200.
[0069] The measurement device (e.g., computer system 330) and/or
therapeutic treatment system (e.g., adapter 100 and slit lamp 200)
can have software stored in a memory and hardware that can be used
to control the taking of images and delivery of therapeutic
treatment (e.g., treatment laser 112) to the patient's retina, the
location or the position (optionally including translations in the
x, y, and z directions and torsional rotations) of the patient's
eye relative to one or more optical axes of the imaging assemblies,
and the like. In exemplary embodiments, among other functions,
computer system 330 (e.g., the measurement device) can be
programmed to calculate treatment areas, boundaries, and/or
patterns 1020 based on the image(s) taken with camera 360, and
measure the offset between the patient's eye in the two images.
Additionally, computer system 330 can be programmed to measure,
effectively in real-time, the movement or position x(t), y(t),
z(t), and rotational orientation of the patient's eye/retina
relative to the optical axis of the laser beam (e.g., treatment
laser 112 and/or aiming laser 122) so as to allow computer system
330 to register or align the desired treatment areas, boundaries,
and/or patterns 1020 on the real-time position of the patient's
eye.
[0070] In order to register the desired treatment areas,
boundaries, and/or patterns 1020 of the patient's eye during the
treatment, the images from the patient's retina taken by the camera
360 should share a common coordinate system. The common coordinate
system may be based a center of the pupil or inner iris boundary, a
center of the outer iris boundary, a center of various veins or
arteries, a center of the optic disc or macula, a center of other
retinal landmarks or features, or any other suitable feature of the
eye.
[0071] As shown in FIG. 10B, one or more desired areas to treat
with the therapeutic treatment may be determined with reference to
diagnostic data associated with a first retinal image 1000 that is
captured by camera 360 and/or previously obtained and input into
computer system 330. A treatment area, boundary, and/or pattern
1020 to use for each respective treatment area may then be
determined. These determinations may be made by a physician with or
without the aid of computer system 330, or, in some embodiments,
may be made automatically by computer system 330. Each treatment
area, boundary, and/or pattern 1020 may be the same or may
vary.
[0072] In some embodiments, the one or more desired treatment
areas, boundaries, and/or patterns 1020 may then be programmed into
computer system 330. Computer system 330 may operate with camera
360 to determine an area of the patient's retina 1012 that
corresponds to the programmed treatment area(s) by comparing the
patient's retina and retinal image 1000. In some embodiments, a
second image of the eye is captured by camera 360, such as
immediately prior to the therapeutic treatment procedure, and the
two images are processed or compared to generate retinal treatment
location information, which information may then be referenced to
the second image. The treatment area(s), boundary(s), and/or
pattern(s) may be superimposed on the patient's retina and/or
displayed on a display interface (e.g., touch screen display 320)
prior to the therapeutic treatment procedure in order to display
the treatment(s) that will be provided and the areas that will
receive such treatment(s). A physician or user may evaluate the
treatment(s) and, if desired, modify or adjust a property (e.g.,
orientation, scale, boundary, pattern, and the like) of one or more
of the treatments.
[0073] In some embodiments, computer system 330 may instruct
adapter 100, or some component of a therapeutic treatment system,
to fire an aiming laser beam (e.g., aiming laser 122) onto the
determined treatment area of retina 1012 to define the treatment
boundary and/or pattern 1020 on retina 1012. In other embodiments,
a treatment boundary and/or pattern may not be defined on the
retina and, thus, an aiming laser may not be needed.
[0074] Computer system 330 may also instruct laser delivery
instrument 310, or other therapeutic treatment system component, to
direct a therapeutic laser beam (e.g., treatment laser 112) onto
the retina 1012 within the treatment area and/or within the
treatment boundary and/or pattern 1020 defined by the aiming laser
beam. The second laser beam (e.g., treatment laser 112) may deliver
the desired therapeutic treatment pulses or doses 1030 (e.g.,
micropulse or other treatment) to retinal tissue within the defined
treatment area and/or treatment boundary and/or pattern 1020 as
shown in FIG. 10C.
[0075] The retinal image 1000 may be stored in a memory device
and/or database for immediate or future reference. As briefly
described above, the therapeutic treatments 1030 provided on the
retinal tissue 1012 may be documented or recorded on the retinal
image 1000 in order to track the treatment or treatments the
patient receives. Documenting/recording of the therapeutic
treatments provided may involve monitoring a position of the
treatment laser beam 112 (i.e., a position of the laser beam axis)
with respect to retinal image 1000 and recording each position of
the treatment laser beam when the treatment laser 112 is fired.
Individual treatment spots or locations may be recorded on retinal
image 1000 to display the areas that have received treatment. Such
mapping and documenting/recording procedures may be particularly
useful in micropulse therapeutic treatment procedures where no
visible effects of the therapeutic treatment are present and
previous micropulse treatments may otherwise been unknown.
[0076] Similarly, a plurality of therapeutic treatments to provide
to a patient over one or more treatment sessions may be mapped or
imaged on retinal image 1000. Each therapeutic treatment
subsequently provided may be documented or recorded on retinal
image 1000, or a second retinal image, so that the actual
therapeutic treatments provided may be compared with the
therapeutic treatments mapped or imaged in order to track an
overall treatment status of the patient or determine the progress
of the treatments and the patient's response to such
treatments.
[0077] Computer system 330 and camera 360 may also be used to
adjust the therapeutic treatment system (e.g., treatment laser 112
and/or aiming laser 122) in response to movement of the patient's
eye. For example, computer system 330 may reference retinal image
1000 with one or more other images provided by camera 360 to
determine whether the patient's eye has moved. In response to
movement of the eye, the position of the aiming laser 122 may be
adjusted so that the projected or defined treatment
boundary/pattern maintains a correct orientation with respect to
the retina. Likewise, the position of the treatment laser 112 may
also be adjusted to compensate for movement of the eye to ensure
that the treatment laser 112 is fired within the adjusted treatment
area, boundary, and/or pattern. The adjustment may include
determining a new position of retinal features of the eye (e.g.,
veins, arteries, macula, and the like), determining a new position
of the treatment boundary/pattern based on the new position of the
retinal features, and adjusting the aiming device 130 accordingly.
The images captured by camera 360 may be provided to computer
system 330 and compared with retinal image 1000 in real time to
provide real time tracking and adjustment of the therapeutic
treatment based on movement of the eye.
[0078] Having described several embodiments, it will be recognized
by those of skill in the art that various modifications,
alternative constructions, and equivalents may be used without
departing from the spirit of the invention. Additionally, a number
of well-known processes and elements have not been described in
order to avoid unnecessarily obscuring the present invention.
Accordingly, the above description should not be taken as limiting
the scope of the invention.
[0079] Where a range of values is provided, it is understood that
each intervening value, to the tenth of the unit of the lower limit
unless the context clearly dictates otherwise, between the upper
and lower limits of that range is also specifically disclosed. Each
smaller range between any stated value or intervening value in a
stated range and any other stated or intervening value in that
stated range is encompassed. The upper and lower limits of these
smaller ranges may independently be included or excluded in the
range, and each range where either, neither or both limits are
included in the smaller ranges is also encompassed within the
invention, subject to any specifically excluded limit in the stated
range. Where the stated range includes one or both of the limits,
ranges excluding either or both of those included limits are also
included.
[0080] As used herein and in the appended claims, the singular
forms "a", "an", and "the" include plural referents unless the
context clearly dictates otherwise. Thus, for example, reference to
"a process" includes a plurality of such processes and reference to
"the device" includes reference to one or more devices and
equivalents thereof known to those skilled in the art, and so
forth.
[0081] Also, the words "comprise," "comprising," "include,"
"including," and "includes" when used in this specification and in
the following claims are intended to specify the presence of stated
features, integers, components, or steps, but they do not preclude
the presence or addition of one or more other features, integers,
components, steps, acts, or groups.
* * * * *